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Summary: The effect of an aqueous extract prepared from the leaves of Viscum album (Mistletoe) on 
plasma cholesterol and albumin levels in male Wistar rats was studied. Lethality studies revealed that 
the extract had an LD50 value of 417.0mg/kg mice, intraperitoneally. The rats were randomly divided 
into seven (7) groups of 5 rats per group with one animal per metabolic cage. Group one served as the 
control (C1), groups two to six were treated with extract (200mg/kg body weight orally and daily) for a 
maximum of ten (10) weeks, whereas, group seven (C2) received no extract treatment but was fed on 
normal rat chow. All the rats had free access to rat food and drinking water. The first group (C1) was 
sacrificed a fortnight after the commencement of the experiment, while group seven (C2) was 
sacrificed at the end (10th week) of the experiment. The extract-treated groups were sacrificed 
respectively in the order 2,4,6,8 and 10 week of extract administration. Whole blood was collected 
from these groups for analysis. Results showed significant increases (P<0.01) in the level of total 
cholesterol (TC) from 1.92 + 0.11mmol/L to 2.59 + 0.02mmol/L (about 35% increase) and high density 
lipoproteins (HDL) from 0.95 + 0.02mmol/L to 1.50 + 0.08mmol/L (about 58.50% increase) at week 
10.  The LDL levels, the total protein and albumin levels did not show any significant change from the 
control values. From the results, it is suggested that the crude aqueous extract from mistletoe leaf may 
be relatively safe for therapeutic use as it neither predisposes to cardiovascular risk nor adversely 
affects protein metabolism following prolonged period of administration.
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Introduction
Viscum album (Mistletoe) is a semi-
parasitic plant with apparent broad spectrum of 
therapeutic action (Hutt et al, 2000, Eno et al.,
2004). Following its wide use and abundance 
in Britain, it is commonly known as “European
mistletoe”. However, there are other species 
spread in various places which may function 
either the same or differently from the 
European mistletoe. It is reported that 
mistletoe is used generally as 
immunomodulatory and anti-cancer agents 
(Bussing, 1990; Hajto, 1999).
Other ailments in which it is used includes the 
treatment of type-1 diabetes mellitus, 
management of serum cholesterol, arthritis, 
hysteria, asthma, hypertension and other 
symptoms connected with raised blood 
pressure (Bussing, 1999). Some human studies 
reported by Newall (1990) had it that mistletoe 
treatment improves quality of life and survival 
rate for people with cancer. In Nigeria, dried 
mistletoe leaves are being sold in sachets to be 
taken as tea in order to provide preventive 
therapy (Eno et al., 2004). 
Hypercholesterolaemia, hypertension and 
atherosclerosis have been identified as 
independent “risk factors” for the development 
of premature cardiovascular diseases (CVD) 
(Chatterjea and Shride, 2002). According to 
Conderce, (1999) and Igwe et al., (2003), high 
level of LDL-cholesterol and low level of 
HDL-cholesterol have been strongly associated 
with the risk of coronary heart disease (CHD). 
Epidermiological data continue to support the 
inverse correlation between HDL-cholesterol 
level and clinically significant atherosclerotic 
disease (Jones, 1998; Zheng et al., 1999). 
Abnormally low level of HDL-cholesterol is 
associated with increased possibility of 
atherosclerosis, probably because of disrupted 
reverse cholesterol transport (Conderce, 1999; 
Chatterjea and Shride, 2002).
In this present studies, effort to assess the 
effect of the leaf extract on the lipid profile and 
plasma proteins in a non-diseased condition 
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was made. Our aim was to investigate if 
patients undergoing mistletoe therapy were 
predisposed to other diseases (e.g. CDC) or 
were capable of suffering from any adverse 
effect (s) of such treatment. 
Materials and Methods
Preparation of Crude Aqueous Extract:
Fresh leaves of Viscum album from the 
host plant (citrus) were collected.  The leaves 
were first washed free of sand and debris.  
Wash water was blotted off and the leaves 
ground to paste.  A quantity of the ground 
sample (50g) was weighed and soxhlet 
extracted with 150ml distilled water at 100°C 
for 8 – 10hr.  Where larger ground samples 
were used, extraction was done under reflux 
with an appropriate volume of distilled water. 
The extract was slowly evaporated to dryness 
in vacuo at 400C using a rotary evaporator. A 
total yield of 31% was obtained.  Weighed 
samples of the extract were then used to 
prepare the stock solution.
Acute Toxicity Study
Seventy male albino Wistar mice 
weighing 18-20g were randomly assigned to 
seven (7) cages of 10 animals per cage. Each 
group respectively received the following 
doses; 50, 100, 200, 400, 800, 1600mg/kg 
body weight of the extract intraperitoneally 
(i.p). The maximum volume injected was 
0.2ml and the control group received 0.2ml of 
normal saline i.p.  The mortality from each 
cage was monitored for 24hours following 
extract administration. Percentage mortalities 
were converted to probits (a probability unit) 
plotted against the log10 of the dose of the 
extract (Eno et al., 2001). From the curve, the 
LD50 value of the extract was extrapolated.
Experimental design
Thirty-five male albino Wistar rats were 
randomly assigned into seven groups of 5 rats 
per group. In all the groups, each rat was 
randomly assigned to a metabolic cage. Group 
one (untreated group) served as the control, 
groups 2-6 were treated with the extract and 
group seven also was untreated (control-2) 
kept throughout the duration of the experiment. 
After 2 weeks acclimatization, the extract was 
administered orally at a dose of 200mg/kg 
body weight per day for 10weeks maximum. 
The animal’s body weights were taken weekly 
to maintain the working dose. The treated 
groups were sacrificed after 2,4,6,8 and 
10weeks of extract administration respectively. 
Group one animals were sacrificed in the first 
fortnight while group seven was in the last day 
of the experiment (10th week). 
Samples collection and preparation
Whole blood sample was collected from 
each group fortnightly. After sedating the 
animals with chloroform, they were dissected 
to expose the heart. Using syringes and 
needles, the blood was collected from the heart 
and stored in the EDTA sample bottles. The 
blood samples were centrifuged at 1000rpm 
for 10minutes. The separated plasma was then 
collected and stored in universal sample bottles 
in the freezer for use in the various analyses. 
Estimation of Plasma cholesterol
Estimation of the total cholesterol (TC) 
and high density lipoprotein (HDL) was by 
spectrophotometric technique using auto-
analysis reagent kits (Tietz, 1994). The low 
density lipoprotein (LDL) was obtained 
mathematically using the formula (Friedewalla 
et al., 1972)
LDL (mmol/L) – Total cholesterol (mmol/L) –
HDL (mmol/L) – TG/22 (mmol/L)
Estimation of Plasma proteins
In the estimation of plasma total proteins 
and albumen, Biuret method was used with 
auto-analysis spectrophotometer.  
Results
Acute Toxicity
Lethality studies showed that the crude 
extract from the leaves of Viscum album
(mistletoe) had an LD50 value of about 
417mg/kg. mice, intraperitoneally. (Fig.1)
Plasma Lipids Profile
The results of the analysis of total 
cholesterol (TC) showed that TC increased 
from the mean control values of 1.29 +
0.1mmol/L to about 2.59 + 0.02mmol/L. This 
increase represented about 35% produced by 
the extract and was significant at P<0.001. 
However, the result also showed that about 
13% of the increase in TC could be attributed 
to age by comparing the first and second 
control groups, suggesting that the actual effect 
of the extract was about 22% increase in TC. 
Fig. 2
The HDL-cholesterol results also showed 
significant increase from 0.95 + 0.05mmol/L 
mean control value to about 1.50 +
0.08mmol/L following the administration of 
the crude extract. Thus, a slight decrease of 
about 6% was observed in the LDL-cholesterol 
level but this was not significant. Fig. 2
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A correlation analysis (Scatter plot) 
showed that there was a positive correlation 
between total cholesterol and HDL-cholesterol 
(r = 0.67, P<0.01, n = 35). Similarly, a positive 
correlation was obtained between TC and 
LDL-cholesterol (r = 0.49, P<0.01, n = 35). 
Based on the correlation coefficient, the 
correlation appears to be stronger for HDL 
than LDL. The HDL:LDL ratio showed that 
the blood concentration of HDL was about 3 
times higher than LDL (3:1). 
Plasma Proteins
The mean total protein concentration in 
plasma was 4.96 + 0.33mg/dL. This value rose 
to about 5.71 + 0.12mg/dL following extract 
administration within the experimental period 
(10weeks). This change was however not 
significant, fig. 3a. The result also showed a 
mean control value of about 3.85 + 0.14mg/dL 
for plasma albumin. After extract 
administration, a mean albumin concentration 
of 4.17 + 0.06mg/dL was obtained. This 
represents about 8% increase and was also not 
significant. Fig. 3b
Fig. 1 Lethality studies showing the effects of administering graded doses 
(50-60mg/kg i.p. mice) of the mistletoe leaf extract against the 






































Fig. 2: Effect of crude aqueous extract of V. album on some plasma lipids in rats.  
Values are mean + SEM, * = P<0.05, ** = P<0.01, *** = P<0.001


















































































Fig. 3a Effect of crude aqueous extract of V. album on total plasma protein 
concentration in rats. Values are mean + SEM.
Fig. 3b Effect of crude aqueous extract of V. album on plasma 
albumin concentration in rats. Values are mean + SEM.  
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Discussion
The effect of V. album (mistletoe) leaf 
extract on a number of the formed elements 
(erythrocytes, leucocytes, thrombocytes) of 
blood is heavily documented (Imoru, 2005). 
Little literature is available on its effects on the 
contents of the fluid portion (plasma) of this 
tissue. The present study was therefore aimed 
at evaluating the effects of this extract on the 
lipid and protein content of plasma, since both 
parameters contribute tremendously to the 
physical and physiological characteristics of 
blood plasma.
The acute toxicity testing showed the LD50
value of aqueous crude extract from mistletoe 
leaves to be very high. This result is consistent 
with that reported by Ohiri (2003) which 
suggested that the extract had a high safety 
margin and may not contain any cardio- or 
neuro- toxic agents. This probably explains 
why there is a widespread use of this extract 
for treatment of diseases and for preventive 
purposes without adverse effects reported. 
With respect to the lipid profile, our 
results suggested a time-dependent increase in 
the plasma total cholesterol (TC) level. This 
result is consistent with previous report that the 
TC increases with age (Chatterjea and Shinde, 
2002). However, this increase in TC could be 
mainly due to the effect of the extract and not 
due to age, since the TC was also increased as 
early as the first fortnight of extract 
administration.
A significant increase in plasma level of 
high density lipoproteins (HDL) was also 
observed. According to Eder and Gidez 
(1982), this increase in HDL can solely be 
responsible for the observed increase in TC 
since the extract might be affecting the HDL 
metabolism in the liver.
The result also showed a slight decrease in 
low density lipoprotein (LDL) levels. This 
observed decrease was however not significant 
in all the treated groups. The extract may be 
having little effects on LDL metabolism. 
Nevertheless, according to Chartterjea and 
Shinde (2002), the slight decrease may be due 
to some influence of the extract on either 
receptor-dependent or receptor independent 
pathways of LDL catabolism in the tissues.
Following the observation that the extract 
increased TC and HDL but failed to influence 
the LDL level, it was deemed necessary to 
investigate which of them (HDL or LDL) 
relates to the TC. Scatter plots constructed 
revealed a positive correlation between the TC 
and HDL and also between TC and LDL. 
However, the plots also revealed that the 
relationship between TC and HDL was more 
marked or stronger than that with LDL. 
Moreover, the HDL to LDL relationship was 
shown to be negative. This probably suggests 
that as the HDL increases, the LDL decreases. 
Therefore, it may be suggested that the 
observed increase in TC was largely due to 
increase in HDL. Also, the analysis of 
HDL/LDL ratio which showed that the HDL 
was much higher than that of LDL is in 
agreement with this view. The report that the 
HDL/LDL ratio is the actual factor responsible 
for the development of atherosclerotic fatty 
streak lesion (Stein and Berg, 1999) is also 
very consistent with this contention. By 
implication, it appears obvious that even 
though the plasma HDL level may be higher 
than that of LDL, this situation may not 
necessarily lead to a cardiovascular disease 
(CVD) risk. Therefore, the crude mistletoe leaf 
extract produced high plasma total cholesterol 
which was effectively distributed between 
HDL and LDL, with a greater portion to the 
HDL side. The extract could lead to 
hyperlipidaemia but not necessarily an 
atherogenic cardiovascular disease risk. This 
view is borne out of the observation that the 
“bad” cholesterol (LDL) was at much lower 
level in the plasma than the “good” cholesterol 
(HDL), following extract administration.
The observation that the extract spared 
both the plasma triglyceride (TG) and the very 
low density lipoprotein (VLDL) may point to 
its lack of any adverse effect on normal liver 
functions. That the liver cells were not affected 
(or destroyed) is further evidenced by the 
steady levels of the plasma total proteins and 
albumin, despite prolonged administration of 
the crude extract. Both plasma protein and 
albumin are preponderate in determining the 
oncotic pressure (Robert and Mathew, 2001), 
and this pressure is the key factor restricting 
fluid loss from capillaries. Therefore, based on 
the lack of effect on the plasma proteins and 
albumin, it may be suggested that the plasma 
viscosity and the volume load of the 
circulatory system was not affected by the sub-
chronic administration of this crude extract. 
Thus, the extract may not have affected the 
health status of the liver adversely, nor alter 
significantly the fluid volume of the body fluid 
compartments.
In conclusion, the crude extract from the 
leaves of Viscum album may not have posed 
any cardiovascular risk since it only increased 
the “good” cholesterol (HDL) level leaving the 
level of the “bad” cholesterol (LDL) 
unaffected.  Also, the failure of the extract to 
alter the plasma levels of TG and VLDL 
probably suggests the normal functioning of 
the liver despite prolonged extract 
administration. That the osmotic oncotic 
Mistletoe increases total plasma cholesterol  and HDL level
59
60
pressure, (which control plasma viscosity and 
the volume load of the circulatory system) was 
also not altered by the extract, is indicated by 
the lack of significant changes in plasma 
proteins and albumin. The high LD50 value 
obtained from this study suggests that the 
extract has a wide safety margin.
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